# DARZALEX

NDC: 57894-502
Generic name: Daratumumab
Labeler / Manufacturer: Janssen Biotech, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20151116

FDA application: BLA761036

## Active ingredients

- DARATUMUMAB: 100 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"57894-502"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=57894-502
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a4d0efe9-5e54-467e-9eb4-56fa7d53b60b